As a clinical pharmacist, you will hear about proton pump inhibitor-induced hypomagnesemia . PPI therapy has been associated with hypomagnesemia, possibly due to reduced magnesium absorption. Hypomagnesemia has been reported after three months of PPI therapy, but the risk increases after a year. Data is conflicting on whether PPI therapy causes hypomagnesemia. Two m…
Read moreNPS | Notes in Pharmacy Specialties is a free, open-access, peer-reviewed site focused on pharmacy practice. Articles are immediately accessible, covering clinical pharmacy, pharmaceutical care, health promotion, informatics, and more.
Egypt - Phone: (+20)1210274589
Gmail: abdelwahabward@gmail.com
Social Plugin